Promising early results from the first human clinical trials with new HIV germline-targeting vaccines were reported. These ...

A little over two decades ago, addressing Nigeria’s HIV crisis topped U.S. President George W. Bush’s priorities. Africa’s ...

Health-related headlines include Mexico's suspension of poultry imports from Brazil due to bird flu, promising results from ...

It’s estimated that over 10 million people around the world develop Alzheimer’s disease annually,” said UVA Health researcher Jayakrishna Ambati, MD. “Our results suggest that taking these drugs could ...

Lenacapavir, however, could provide protection for an entire year with just a single injection. This would make it the longest-acting form of HIV prevention available if it successfully passes ...

People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA ...

Share on Pinterest New research suggests that HIV drugs may have a protective effect against Alzheimer’s. Willie B. Thomas/Getty Images Researchers at UVA Health have found that a class of HIV ...

Nucleoside reverse transcriptase inhibitors (NRTIs) are used to prevent HIV and hepatitis B from replicating ... To see whether that action could protect against Alzheimer’s, the researchers ...

The sample was drawn from a geographically targeted, ethnically diverse field setting in Houston identified as having high levels of HIV transmission risk behaviors by police records of drug ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer’s disease after discovering that patients taking the drugs are ...